BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BOPA - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BOPA
X-ORIGINAL-URL:https://www.bopa.org.uk
X-WR-CALDESC:Events for BOPA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20200206T093000
DTEND;TZID=Europe/Paris:20200206T170000
DTSTAMP:20260502T041738
CREATED:20200117T094909Z
LAST-MODIFIED:20200117T094909Z
UID:5768-1580981400-1581008400@www.bopa.org.uk
SUMMARY:CAR-T and Immunocellular Therapies: A New Class of Medicines
DESCRIPTION:Chimeric Antigen Receptor T-cell therapy (CAR-T) is an immunocellular therapy. This novel class of medicines\, often referred to as Advanced Therapy Medicinal Products – ATMPs\, are new and complex biological treatments. ATMPs can potentially transform the lives of patients who have treatment resistant blood cancers. As with most complex therapies\, there can be serious and sometimes life-threatening complications to this novel and advanced technology. Every healthcare professional in contact with patients undergoing this treatment\, both now and in the future\, should be aware of immunocellular/ATMP therapy. \nThis exciting event\, jointly hosted by RPS and King’s College Hospital\, will equip you with knowledge\, skills and confidence to be able to understand CAR-T / ATMP therapy and its place in clinical medicine\, now and in the future. \nRegistration Details:  Event price £75 for RPS members and £145 for non-members.  Register via RPS website at https://events.rpharms.com/ereg/newreg.php?eventid=200197071&language=eng \nAddress of event: Royal Pharmaceutical Society\, 66-68 East Smithfield\, London\, E1W 1AW \nDeadline date for registration: N/A \nItinerary: See agenda at https://events.rpharms.com/website/993/home/agenda/
URL:https://www.bopa.org.uk/event/car-t-and-immunocellular-therapies-a-new-class-of-medicines/
ORGANIZER;CN="Royal Pharmaceutical Society and King's College Hospital NHS Foundation Trust":MAILTO:rpsevents@rpharms.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200212
DTEND;VALUE=DATE:20200213
DTSTAMP:20260502T041738
CREATED:20190708T090632Z
LAST-MODIFIED:20190708T090656Z
UID:1176-1581465600-1581551999@www.bopa.org.uk
SUMMARY:American Society of Clinical Oncology (ASCO) 2020 ABSTRACT Deadline
DESCRIPTION:ABSTRACT Deadline (Approx date)
URL:https://www.bopa.org.uk/event/american-society-of-clinical-oncology-asco-2020-abstract-deadline/
END:VEVENT
END:VCALENDAR